Nifelat Q en es it fr

Nifelat Q Brand names, Nifelat Q Analogs

Nifelat Q Brand Names Mixture

  • No information avaliable

Nifelat Q Chemical_Formula


Nifelat Q RX_link

Nifelat Q fda sheet

Nifelat_Q FDA

Nifelat Q msds (material safety sheet)

Nifelat_Q MSDS

Nifelat Q Synthesis Reference

Bossert, Vater, U.S. Pat. 3,485,847 (1969)

Nifelat Q Molecular Weight

346.335 g/mol

Nifelat Q Melting Point

172 - 174 oC

Nifelat Q H2O Solubility


Nifelat Q State


Nifelat Q LogP


Nifelat Q Dosage Forms

Capsule; Tablet; Tablet (extended-release)

Nifelat Q Indication

For the management of vasospastic angina, chronic stable angina and hypertension.

Nifelat Q Pharmacology

Nifedipine, the prototype of the dihydropyridine class of calcium-channel antagonists, is similar to other dihydropyridines including amlodipine, felodipine, isradipine, and nicardipine. Nifedipine is used to treat Prinzmetal's angina, hypertension, and other vascular disorders such as Raynaud's phenomenon. By blocking the calcium channels, Nifedipine inhibits the spasm of the coronary artery and dilates the systemic arteries, results in a increase of myocardial oxygen supply and a decrease in systemic blood pressure.

Nifelat Q Absorption

Rapidly and fully absorbed following oral administration.

Nifelat Q side effects and Toxicity

Symptoms of overdose include dizziness, drowsiness, nausea, severe drop in blood pressure, slurred speech, and weakness. LD50=494 mg/kg (orally in mice); LD50=1022 mg/kg (orally in rats)

Nifelat Q Patient Information

Nifelat Q Organisms Affected

Humans and other mammals